ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750335 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750335; 2) Community: the network communities that were significantly associated with the response to NSC 750335; 3) Molecule: the relationships between components within communities and NSC 750335; 4) MDR: the compounds that were significantly associated with the NSC 750335.

NSC Compound Enrichment Correlation
NSC 692578 Null 0.0414190425892871 0.15868025
NSC 69577 Null 0.0414190425892871 0.30186419
NSC 701383 Null 0.0414190425892871 -0.040346474
NSC 710549 Null 0.0414190425892871 -0.15978875
NSC 71669 Null 0.0414190425892871 -0.077574188
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0414190425892871 -0.066914567
NSC 721049 7Z-Plakortide H 0.0414190425892871 0.016610365
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0414190425892871 -0.085451833
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0414190425892871 0.050467685
NSC 740 Methotrexate 0.0414190425892871 -0.11179567
Total:78  Current:71    [First] [Prev] [Next] [Last]